Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Harsha P Panchal"'
Autor:
Ananya Pareek, Apurva A. Patel, Mukesh Kumar, Philip G. Kuttikat, Harshavardhan Annadanam, Shantanu Pendse, Naseer Mohammed, Harsha P. Panchal
Publikováno v:
South Asian Journal of Cancer, Vol 11, Iss 01, Pp 058-061 (2022)
Abstract Apurva A. Patel Ananya Pareek Background Immunotherapy is a proven therapeutic option in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) after platinum therapy. At present, there are no published Indian data regardi
Externí odkaz:
https://doaj.org/article/a42665d3283f4e3dab1f12e7d64a3983
Autor:
Rahul Suhas Kulkarni, Asha S Anand, Sonia K Parikh, Harsha P Panchal, Apurva A Patel, Dhruv P Mehta, Priyanka Patel
Publikováno v:
South Asian Journal of Cancer, Vol 8, Iss 3, Pp 198-202 (2019)
Background: Most of the data on neuroendocrine tumors (NETs) are from the Western literature. Indian studies regarding clinicopathological characteristics and treatment outcomes are lacking. Methods: This is a prospective observational study of all n
Externí odkaz:
https://doaj.org/article/bc5053fd377247668519904b3b0a44e6
Autor:
Rahul S Kulkarni, Asha S Anand, Apurva A Patel, Sandip A Shah, Harsha P Panchal, Sonia K Parikh, Hemangini H Vora, Biren P Parikh, Avinash Talele
Publikováno v:
Journal of Applied Hematology, Vol 7, Iss 2, Pp 70-75 (2016)
Granulocytic sarcoma (GS), also called myeloid sarcoma is an extramedullary tumor of the immature granulocytic cells. It is a rare entity and mostly accompanied by acute myeloid leukemia (AML). Very rarely, it is detected before clinical signs of leu
Externí odkaz:
https://doaj.org/article/7717594549b04bc3adc7096df6b38bb2
Autor:
Sandeep R Kukkar, Harsha P Panchal, Asha S Anand, Apurva A Patel, Sonia P Parikh, Sandip A Shah
Publikováno v:
Journal of Applied Hematology, Vol 7, Iss 4, Pp 136-140 (2016)
Background: Tumor lysis syndrome (TLS) is an oncological emergency. Rasburicase (recombinant urate oxidase) has been proven to be an effective therapy for prevention of TLS and its serious consequences in patients with hematological malignancies such
Externí odkaz:
https://doaj.org/article/062848526ecb4ad0bb33d64d0ec7de98
Publikováno v:
Journal of Applied Hematology, Vol 6, Iss 2, Pp 53-57 (2015)
Severe aplastic anemia (SAA) is a serious bone marrow disease that needs a comprehensive and service-intense treatment with either bone marrow transplantation (BMT) or immunosuppressive therapy (IST); both are difficult to optimally offer in resource
Externí odkaz:
https://doaj.org/article/8367f0ff50ac4db188f790882d2dd3fc
Autor:
Sharma, Satish, Apurva A Patel, Aruj Dhyani, Nikesh Aggarwal, Yuganshi Gupta, Goutham R Reddy, Debajyoti Maji, Harshvardhan A, Kuttikat, Phillip G, Ananya Pareek, Parikh, Sonia, Harsha P Panchal
Treatment of multi-resistant ovarian cancer is palliative. Patient after receiving multiple lines of chemotherapy are neither in good PS nor have good compliance to receive further toxic treatment. Bevacizumab is a vascular endothelial growth factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87652c92dd2f32bf0c281b1512e34e7e
Autor:
Ananya, Pareek, Apurva A, Patel, Mukesh, Kumar, Philip G, Kuttikat, Harshavardhan, Annadanam, Shantanu, Pendse, Naseer, Mohammed, Harsha P, Panchal
Publikováno v:
South Asian Journal of Cancer (2021)
Background Immunotherapy is a proven therapeutic option in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) after platinum therapy. At present, there are no published Indian data regarding administration of nivolumab in this set
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a07ded9188a459513d4fcee7def8de8
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1733317
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1733317
Autor:
Harsha P Panchal
Publikováno v:
Advances in Cancer Prevention.
Cancer is one of the communicable diseases killing the mankind and is likely to be a global pandemic by year 2050. Fifty percent of cancers are preventable because of the causal association with modifiable risk factors. Preventive oncology is any mea
Autor:
Harsha P Panchal
Publikováno v:
Advances in Cancer Prevention.
Autor:
Sonia K Parikh, Shilin N Shukla, Pankaj M Shah, Kirti M Patel, Bharat J Parikh, Asha S Anand, Shailesh S Talati, Sandip A Shah, Harsha P Panchal, Apoorva A Patel
Publikováno v:
Indian Journal of Medical and Paediatric Oncology. 25:5-9